Jason J Marineau

This inventor holds 20 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Cancer Therapeutics. Top assignees: Syros Pharmaceuticals, Inc., Dana-Farber-Cancer Institute Inc., University of Massachusetts. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason J Marineau. Retrieved from https://idiyas.com/inventor/jason-j-marineau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 19)

% Patents Active = 85.0

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 77(Granted Patents)

Company Filing History:

16 out of 24

Syros Pharmaceuticals, Inc.

patents

5 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

1 out of 1,630

University of Massachusetts

patents

4. 1 out of 318

Whitehead Institute for Biomedical Research

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

CDK7 Inhibitors

Myc Activity

Proliferative Diseases

Heteroaromatic Compounds

Pyrrolotriazine Compounds

Polycyclic Inhibitors

Transcription Factors

Cancer Treatment

Kinase Inhibition

Pharmaceutical Compounds

Oncology Research

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240869 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2025-03-04),

2. 11918592 - Inhibitors of cyclin dependent kinase 7 (CDK7) (2024-03-05),

3. 11753418 - Compounds for the modulation of Myc activity (2023-09-12),

4. 11311542 - Inhibitors of cyclin dependent kinase 7 (CDK7) (2022-04-26),

5. 11274103 - Compounds for the modulation of MYC activity (2022-03-15),

6. 11124527 - Compounds for the modulation of Myc activity (2021-09-21),

7. 11040981 - Pyrrolotriazine compounds and methods of inhibiting TAM kinases (2021-06-22),

8. 11040957 - Heteroaromatic compounds useful for the treatment of proliferative diseases (2021-06-22),

9. 10906889 - Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) (2021-02-02),

10. 10865206 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2020-12-15),

11. 10787444 - Compounds for the modulation of myc activity (2020-09-29),

12. 10738067 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2020-08-11),

13. 10519135 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2019-12-31),

14. 10336760 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2019-07-02),

15. 10308648 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2019-06-04),

Title: Jason J Marineau - Innovative Inventor from Franklin, MA

Introduction: Jason J Marineau is a talented inventor hailing from Franklin, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jason J Marineau holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Jason J Marineau has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Jason J Marineau has collaborated with top engineers, scientists, and designers to bring his ideas to life, resulting in successful products and technologies that have had a significant impact on society.

Conclusion: Jason J Marineau's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs in Franklin, MA and beyond.

Profile summary based on public USPTO records.